Literature DB >> 33937575

Combating COVID-19 as a designated hospital: Experience from Shanghai, China.

Jingjing Hui1, Haiyan Li1, Feng Gao1, Qiuping Shang1, Jiao Wang1, Hongzhou Lu1.   

Abstract

Many large international cities, such as Shanghai, are facing the threat of more imported cases of COVID-19 because of the frequent flow of people and objects at home and abroad. In the face of the complex and changing disease status of the international community, dealing with this disease effectively is a great challenge to the city's existing public health emergency response capacity and also a major test of designated COVID-19 hospitals. Here, we share our experience as a designated COVID-19 hospital in Shanghai, China in terms of i) A Professional Multi-disciplinary Team, ii) Personalized Treatment Plans for Patients in Severe or Critically Ill Condition, iii) Well-organized Classification of Patients, iv) Establishment of Transitional Wards, v) Nosocomial Infection Prevention and Control, and vi) Identification and Reporting of the Asymptomatic in the hopes that these approaches can serve as a reference for healthcare providers and medical staff who are fighting the pandemic. 2021, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; asymptomatic; designated hospital; treatment

Year:  2021        PMID: 33937575      PMCID: PMC8071678          DOI: 10.35772/ghm.2020.01079

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  2 in total

1.  [Suggestions on reforming and improving the prevention and treatment system for major epidemic diseases in China].

Authors:  L M Li; S Y Zhan; H Chi; Y Deng; L Wang; B Wang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-07-10

2.  A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.

Authors:  Vincent J Munster; Marion Koopmans; Neeltje van Doremalen; Debby van Riel; Emmie de Wit
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.